Supernus Pharmaceuticals Inc (SUPN)
Depreciation & Amortization
$101.71M
TTM · Period ending: · USD
SUPN Depreciation & Amortization
Latest reported$101.71Mperiod ending
Latest reported$101.71Mperiod ending
SUPN TTM Depreciation & Amortization ($879.00K → $101.71M)
TTM Depreciation & Amortization
High-resolution chart · PNG
SUPN depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 101,713,000 | |
| 97,324,000 | |
| 91,563,000 | |
| 85,392,000 | |
| 80,688,000 | |
| 80,048,000 | |
| 80,414,000 | |
| 83,245,000 | |
| 85,000,000 | |
| 85,007,000 | |
| 84,859,000 | |
| 84,032,000 | |
| 83,950,000 | |
| 84,782,000 | |
| 85,543,000 | |
| 77,401,000 | |
| 62,301,000 | |
| 47,365,000 | |
| 32,595,000 | |
| 25,408,000 | |
| 26,576,000 | |
| 23,001,000 | |
| 18,141,000 | |
| 14,251,000 | |
| 8,082,000 | |
| 7,063,000 | |
| 7,010,000 | |
| 7,072,000 | |
| 7,282,000 | |
| 7,035,000 | |
| 7,063,000 | |
| 7,041,000 | |
| 9,535,000 | |
| 9,098,000 | |
| 8,132,000 | |
| 7,133,000 | |
| 3,366,000 | |
| 2,711,000 | |
| 2,399,000 | |
| 1,998,000 | |
| 1,607,000 | |
| 1,136,000 | |
| 921,000 | |
| 878,000 | |
| 899,000 | |
| 915,000 | |
| 928,000 | |
| 917,000 | |
| 876,000 | |
| 807,000 | |
| 742,000 | |
| 747,000 | |
| 759,000 | |
| 808,000 | |
| 871,000 | |
| 878,000 | |
| 890,000 | |
| 896,000 | |
| 879,000 | |
| 949,352 | |
| 1,007,755 |